Thymic stromal lymphopoietin (TSLP) is a cytokine similar to IL-7, which is released by airway epithelial cells in response to injury and inflammation. Current literature is contradictory about the association between different single nucleotide polymorphisms (SNPs) of the TSLP gene and asthma development in different countries. We aimed to evaluate the association between two common TSLP SNPs (rs2289276 and rs2289278) and the risk of asthma in the Iranian population. Genotyping of the TSLP gene was performed in 126 adult asthmatic patients and 300 controls; using the TaqMan genotyping assay. Moreover, total serum IgE level and eosinophil count were assessed. The results indicated that the TT genotype of rs2289276 was inversely associated with the risk of asthma (p=0.002). A similar inverse association was detected in subgroups of atopic (p=0.001) and non-atopic (p=0.005) asthma. Moreover, the TT genotype of this SNP was more prevalent in severe and late-onset categories of asthma. In subgroup analysis, a significant sex-specific association between rs2290276 and asthma was observed in women (p=0.004). The prevalence of rs2289276 was extremely low, which made it infeasible to perform any further analysis. Overall, our findings indicated that rs2290276 SNP of the TSLP gene has a protective phenotype against asthma development in the Iranian population.
1 July 2023 in European Annals of Allergy and Clinical Immunology
Griscelli syndrome (GS) type 2 is an inborn error of the immune system classified as immune dysregulation. This autosomal recessive disease has three types with different genetic causes. In all variants, hypopigmentation is common, but neurological involvement or immunodeficiency varies in severity. The known genetic defects associated with GS include mutations in myosin 5 A (GS type1), guanosine triphosphate binding protein (GS type 2), and human melanophilin (GS type 3). Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition and is characterized by severe, ineffective, and uncontrolled inflammatory reactions. A HLH can be classified as primary or secondary, with secondary resulting from autoimmunity, malignancy, spontaneous or infectious causes. Many prenatal infections can cause long-term complications in the fetus, including toxoplasmosis, rubella, cytomegalovirus, herpes simplex, syphilis, parvovirus, and varicella zoster (known as TORCH syndrome). Prenatal infections have been associated with TORCH for a long time, but HLH is a rare complication. The report presents a case of HLH with symptoms of sepsis, organomegaly, and cytopenia from the time of birth. A genetic test confirmed Griscelli Syndrome Type 2, which was diagnosed during an immunologic consultation regarding partial albinism not seen in family members. Prenatal infection was the only approved finding in the investigation into the trigger of HLH in this patient starting in the first days of life. Accordingly, the patient was diagnosed with type 2GS syndrome with neonatal-onset HLH caused by a prenatal infection.
19 April 2021 in Iranian Journal of Allergy, Asthma and Immunology
Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome is a rare primary immunodeficiency disorder characterized by recurrent infections and low immunoglobulin levels due to variable combined immunodeficiency, and centromeric region instability, and facial dysmorphism. We describe a 12-year-old boy with recurrent respiratory tract infections, facial anomalies, scoliosis, and psychomotor retardation. He had recurrent pneumonia with low serum IgG and IgM levels during infancy and preschool age. Later at the age of 10, he developed recurrent ear infections. An IgA and IgM deficiency was found accompanied by a normal B-cell and T-cell count as well as an impaired candida-induced T-cell proliferation. Further evaluations revealed a missense mutation in the DNMT3B gene on chromosome 20. Chromosomal analysis showed a sunburst multi-radial feature on chromosome 1, which is a hallmark of ICF syndrome. The genetic mutation and chromosomal abnormality along with clinical findings are compatible with the diagnosis of ICF syndrome. To the best of our knowledge, this is the first time that scoliosis is observed in an ICF patient. The additional variable clinical symptoms in the case were the presence of spastic gait as well as hypogammaglobulinemia with immunoglobulin isotype switch at different ages.